Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Åsa Danielsson Borssén, Hanns-Ulrich Marschall, Annika Bergquist, Fredrik Rorsman, Ola Weiland, Stergios Kechagias, Nils Nyhlin, Hans Verbaan, Emma Nilsson & Mårten Werner. (2017) Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis. Scandinavian Journal of Gastroenterology 52:9, pages 1022-1028.
Read now
Read now
Nwe Ni Than, Christiane Wiegard, Christina Weiler-Normann, Katja Füssel, Jake Mann, James Hodson, Gideon M. Hirschfield, Ansgar W. Lohse, David H. Adams, Christoph Schramm & Ye Htun Oo. (2016) Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. Scandinavian Journal of Gastroenterology 51:3, pages 329-336.
Read now
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
Read now
Articles from other publishers (49)
David U. Lee, Kimberly Schuster, Aneesh Bahadur, Sophie Schellhammer, Reid Ponder, Emma Mitchell-Sparke, Gregory H. Fan, Ki J. Lee, Harrison Chou & Zurabi Lominadze. (2024) Trends of Costs and Admission Rates Among Patients Admitted With Autoimmune Hepatitis: Analysis of US Hospitals Using the NIS Database. Journal of Clinical and Experimental Hepatology 14:1, pages 101279.
Crossref
Crossref
Laura Harrison, Barbara Hoeroldt, Harpreet Dhaliwal, Elaine Wadland, Asha Dube & Dermot Gleeson. (2023) Long-term Outcome of Autoimmune Hepatitis: Consecutive Patient Cohort and Data on the Second Twenty Years. Digestive and Liver Disease 55:11, pages 1515-1520.
Crossref
Crossref
Matthias Buechter, Dominik Dorn, Birte Möhlendick, Winfried Siffert, Hideo A. Baba, Guido Gerken & Alisan Kahraman. (2023) Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center. Journal of Clinical Medicine 12:13, pages 4192.
Crossref
Crossref
Stephan Zandanell, Lorenz Balcar, Georg Semmler, Alex Schirmer, Isabella Leitner, Lea Rosenstatter, David Niederseer, Karl Sotlar, Anna-Maria Schneider, Michael Strasser, Sophie Gensluckner, Alexandra Feldman, Christian Datz & Elmar Aigner. (2023) Genetic Variants Determine Treatment Response in Autoimmune Hepatitis. Journal of Personalized Medicine 13:3, pages 540.
Crossref
Crossref
Bridget Whitehead & Alyssa Kriegermeier. (2022) Natural history and management of refractory autoimmune hepatitis. Clinical Liver Disease 20:4, pages 120-123.
Crossref
Crossref
Maaike Biewenga, Xavier Verhelst, Martine Baven-Pronk, Hein Putter, Aad van den Berg, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe Van Steenkiste, Hans van Vlierberghe, Adriaan van der Meer, Bart van Hoek, G. Bouma, Y. de Boer, J.P.H. Drenth, N.M. van Gerven, U. Beuers, K.J. van Erpecum, J.W. den Ouden, A. Bhalla, J.T. Brouwer, J.M. Vrolijk, G.H. Koek, M.M.J. Guichelaar, E.J. van der Wouden, J.J.M. van Meyel, L.C. Baak, R.C. Verdonk, M. Klemt-Kropp, M.A.M.T. Verhagen, J.Ph. Kuijvenhoven & H.M. de Jonge. (2022) Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis. Clinical Gastroenterology and Hepatology 20:8, pages 1776-1783.e4.
Crossref
Crossref
Victoria Gordon, Ratul Adhikary, Victoria Appleby, Debasish Das, James Day, Toby Delahooke, Selena Dixon, David Elphick, Claire Hardie, Michael A. Heneghan, Barbara Hoeroldt, Patricia Hooper, John Hutchinson, Rebecca Jones, Faisal Khan, Guruprasad P. Aithal, Jane Metcalf, Alick Nkhoma, Stavroula Pelitari, Martin Prince, Annell Prosser, Vinay Sathyanarayana, Sushma Saksena, Deven Vani, Andrew Yeoman, George Abouda, Andrew Nelson & Dermot Gleeson. (2022)
Treatment and outcome of autoimmune hepatitis: Audit of 28
UK
centres
. Liver International 42:7, pages 1571-1584.
Crossref
Crossref
I. M. Iljinsky & O. M. Tsirulnikova. (2022) Historical aspects and current understanding of autoimmune hepatitis. When is liver transplantation indicated? (Review). Russian Journal of Transplantology and Artificial Organs 24:2, pages 39-50.
Crossref
Crossref
Michele May-Sien Tana, Arielle Klepper, Amy Lyden, Angela Oliveira Pisco, Maira Phelps, Breann McGee, Kelsey Green, Sandy Feng, Joseph DeRisi, Emily Dawn Crawford & Craig S. Lammert. (2022) Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management. PLOS ONE 17:3, pages e0264307.
Crossref
Crossref
Sara Lemoinne, Alexandra Heurgue, Charlotte Bouzbib, Bertrand Hanslik, Jérôme Gournay, Eric Nguyen-Khac, Christophe Bureau, Victor de Lédinghen, Nathalie Ganne-Carrié & Marc Bourlière. (2022) Non-invasive diagnosis and follow-up of autoimmune hepatitis. Clinics and Research in Hepatology and Gastroenterology 46:1, pages 101772.
Crossref
Crossref
Rajani Sharma, Elizabeth C. Verna, Jonas Söderling, Bjorn Roelstraete, Hannes Hagström & Jonas F. Ludvigsson. (2021) Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology. Clinical Gastroenterology and Hepatology 19:12, pages 2636-2647.e13.
Crossref
Crossref
Maaike Biewenga, Xavier P.D.M.J. Verhelst, Martine A.M.C. Baven‐Pronk, Hein Putter, Aad P. van den Berg, Karin C.M.J. van Nieuwkerk, Henk R. van Buuren, Gerd Bouma, Ynte S. de Boer, Cedric Simoen, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe van Steenkiste, Hans van Vlierberghe, Adriaan J. van der Meer, Frederik Nevens & Bart van Hoek. (2021) Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1. United European Gastroenterology Journal 9:6, pages 662-671.
Crossref
Crossref
Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Takemi Akahane, Akira Mitoro, Junichi Yamao & Hitoshi Yoshiji. (2021) Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis. Journal of Clinical Medicine 10:11, pages 2465.
Crossref
Crossref
Sanchit Sharma, Samagra Agarwal, Kanav Kaushal, Abhinav Anand, Deepak Gunjan, Rajni Yadav & Anoop Saraya. (2020) Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids. JGH Open 5:1, pages 81-90.
Crossref
Crossref
Lisbet Grønbæk, Harmony Otete, Lu Ban, Colin Crooks, Timothy Card, Peter Jepsen & Joe West. (2020) Incidence, prevalence and mortality of autoimmune hepatitis in England 1997‐2015. A population‐based cohort study. Liver International 40:7, pages 1634-1644.
Crossref
Crossref
Abbas Ali Tasneem & Nasir Hassan Luck. (2020) Autoimmune hepatitis: Clinical characteristics and predictors of biochemical response to treatment. Journal of Translational Internal Medicine 8:2, pages 106-111.
Crossref
Crossref
Kjartan B. Valgeirsson, Jóhann P. Hreinsson & Einar S. Björnsson. (2019) Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver International 39:12, pages 2341-2349.
Crossref
Crossref
Chi Zhang, Shan-Shan Wu, Xiao-Qin Dong, Zhao Wu, Hong Zhao & Gui-Qiang Wang. (2019) The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis. Medicine 98:52, pages e18313.
Crossref
Crossref
Dermot Gleeson. (2019) Long‐Term Outcomes of Autoimmune Hepatitis. Clinical Liver Disease 14:1, pages 24-28.
Crossref
Crossref
Floris F. van den Brand, Koen S. van der Veen, Ynto S. de Boer, Nicole M. van Gerven, Birgit I. Lissenberg-Witte, Ulrich Beuers, Karel J. van Erpecum, Henk R. van Buuren, Jannie W. den Ouden, Johannus T. Brouwer, Jan M. Vrolijk, Robert C. Verdonk, Bart van Hoek, Ger H. Koek, Joost P.H. Drenth, Marleen M.J. Guichelaar, Chris J.J. Mulder, Elisabeth Bloemena, Carin M.J. van Nieuwkerk, Gerd Bouma, T.C.M.A. Schreuder, E.J. van der Wouden, J.J.M. van Meyel, L.C. Baak, P.H.G.M. Stadhouders, M. Klemt-Kropp, M.A.M.T. Verhagen, A. Bhalla & J.Ph. Kuijvenhoven. (2019) Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 17:5, pages 940-947.e2.
Crossref
Crossref
K L Raikhelson & E A Kondrashina. (2019) Ademethionine in the treatment of fatigue in liver diseases: a systematic review. Terapevticheskii arkhiv 91:2, pages 134-142.
Crossref
Crossref
Martine A. M. C. Baven-Pronk, Maaike Biewenga, Joanne J. van Silfhout, Aad P. van den Berg, Henk R. van Buuren, Bart J. Verwer, Carin M. J. van Nieuwkerk, Gerd Bouma & Bart van Hoek. (2018) Role of age in presentation, response to therapy and outcome of autoimmune hepatitis. Clinical and Translational Gastroenterology 9:6, pages e165.
Crossref
Crossref
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani & Diego Vergani. (2017) Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 23:33, pages 6030-6048.
Crossref
Crossref
Rubén Peña-Vélez & Enory Almanza-Miranda. (2017) Hepatitis autoinmune en la edad pediátrica. Boletín Médico del Hospital Infantil de México 74:5, pages 324-333.
Crossref
Crossref
Åsa D. Borssén, Richard Palmqvist, Stergios Kechagias, Hanns-Ulrich Marschall, Annika Bergquist, Fredrik Rorsman, Ola Weiland, Hans Verbaan, Nils Nyhlin, Emma Nilsson & Mårten Werner. (2017) Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis. Medicine 96:34, pages e7708.
Crossref
Crossref
Richard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, Claudine Lalanne, Danny Jonigk, Jerome Schlue, Till Krech, Ralf Lichtinghagen, Christine S. Falk, Verena Schlaphoff, Heike Bantel, Luigi Muratori, Michael P. Manns & Elmar Jaeckel. (2017) Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLOS ONE 12:6, pages e0179074.
Crossref
Crossref
Sina Hübener, Ye Htun Oo, Nwe Ni Than, Peter Hübener, Christina Weiler-Normann, Ansgar W. Lohse & Christoph Schramm. (2016) Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance. Clinical Gastroenterology and Hepatology 14:3, pages 445-453.
Crossref
Crossref
Craig Lammert, Veronica M. Loy, Kiyoko Oshima & Samer Gawrieh. (2016) Management of Difficult Cases of Autoimmune Hepatitis. Current Gastroenterology Reports 18:2.
Crossref
Crossref
Naoki Matsumoto, Masahiro Ogawa, Shunichi Matsuoka & Mitsuhiko Moriyama. (2016) Prevalence and Risk Factors of Diabetes Mellitus in Patients with Autoimmune Hepatitis. Internal Medicine 55:8, pages 879-885.
Crossref
Crossref
. (2015) EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 63:4, pages 971-1004.
Crossref
Crossref
Fan Yang, Qixia Wang, Zhaolian Bian, Lin-Lin Ren, Jidong Jia & Xiong Ma. (2015) Autoimmune hepatitis: East meets west. Journal of Gastroenterology and Hepatology 30:8, pages 1230-1236.
Crossref
Crossref
Harpreet K Dhaliwal, Barbara S Hoeroldt, Asha K Dube, Elaine McFarlane, James C E Underwood, Mohammed A Karajeh & Dermot Gleeson. (2015) Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis. American Journal of Gastroenterology 110:7, pages 993-999.
Crossref
Crossref
Ayman A. Abdo & Faisal M. Sanai. 2015. Cirrhosis: A practical guide to management. Cirrhosis: A practical guide to management
301
310
.
Lisbet Grønbæk, Hendrik Vilstrup & Peter Jepsen. (2014) Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. Journal of Hepatology 60:3, pages 612-617.
Crossref
Crossref
Fumi Varyani, Timothy Card, Philip Kaye, Guru P Aithal & Joe West. (2013) The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study. BMC Health Services Research 13:1.
Crossref
Crossref
Jing Hieng Ngu, Richard Blair Gearry, Chris Miles Frampton & Catherine A.M. Stedman. (2013) Predictors of poor outcome in patients w ith autoimmune hepatitis: A population-based study. Hepatology 57:6, pages 2399-2406.
Crossref
Crossref
Richard Parker, Ye Htun Oo & David H. Adams. (2012) Management of patients with difficult autoimmune hepatitis. Therapeutic Advances in Gastroenterology 5:6, pages 421-437.
Crossref
Crossref
V. Selvarajah, A. J. Montano‐Loza & A. J. Czaja. (2012) Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 36:8, pages 691-707.
Crossref
Crossref
Harpreet K. Dhaliwal, Rory Anderson, Elizabeth L. Thornhill, Sarah Schneider, Elaine McFarlane, Dermot Gleeson & Lynne Lennard. (2012) Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis. Hepatology 56:4, pages 1401-1408.
Crossref
Crossref
Andrea A. Gossard & Keith D. Lindor. (2012) Autoimmune hepatitis: a review. Journal of Gastroenterology 47:5, pages 498-503.
Crossref
Crossref
Graciela Landeira, Silvia Morise, Eduardo Fassio, Margarita Ramonet, Estela Álvarez, Patricia Caglio, Cristina Longo & Nora DomÍnguez. (2012) Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis. Annals of Hepatology 11:1, pages 100-106.
Crossref
Crossref
Julia L. Newton & David E.J. Jones. (2012) Managing systemic symptoms in chronic liver disease. Journal of Hepatology 56, pages S46-S55.
Crossref
Crossref
S. Wirth. (2011) Chronische Hepatitiden bei Kindern und JugendlichenChronic hepatitis in children and adolescents. Der Gastroenterologe 6:6, pages 477-485.
Crossref
Crossref
Christoph Schramm & Ansgar W. Lohse. (2011) Role of mycophenolate mofetil in the treatment of autoimmune hepatitis. Journal of Hepatology 55:3, pages 510-511.
Crossref
Crossref
Marlyn J Mayo. (2011) Management of autoimmune hepatitis. Current Opinion in Gastroenterology 27:3, pages 224-230.
Crossref
Crossref
Miriam L. Cuarterolo, Mirta E. Ciocca, Susana I. López, María T.G. de Dávila & Fernando Álvarez. (2011) Immunosuppressive Therapy Allows Recovery From Liver Failure in Children With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 9:2, pages 145-149.e1.
Crossref
Crossref
Christian P. Strassburg. (2010) Autoimmune hepatitis. Best Practice & Research Clinical Gastroenterology 24:5, pages 667-682.
Crossref
Crossref
Edith M.M. Kuiper, Pieter E. Zondervan & Henk R. van Buuren. (2010) Paris Criteria Are Effective in Diagnosis of Primary Biliary Cirrhosis and Autoimmune Hepatitis Overlap Syndrome. Clinical Gastroenterology and Hepatology 8:6, pages 530-534.
Crossref
Crossref
Victoria Gordon, Ratul Adhikary, Victoria Appleby, Debasish Das, James Day, Toby Delahooke, Selena Dixon, David Elphick, Claire Hardie, Michael A. Heneghan, Barbara Hoeroldt, Patricia Hooper, John Hutchinson, Rebecca Jones, Faisal Khan, Guruprasad Padur Aithal, Jane Metcalf, Alick Nkhoma, Stavroula Pelitari, Martin Prince, Annell Prosser, Vinay Sathanarayana, Sushma Saksena, Deven Vani, Andrew Yeoman, George Abouda, Andrew Nelson, Dermot Gleeson & UK Multi-Centre AIH Audit Group. (2021) Treatment and Outcome of Autoimmune Hepatitis (AIH): Audit of 28 UK Centres. SSRN Electronic Journal.
Crossref
Crossref